| Literature DB >> 32509342 |
Gábor Tóth1, Milán Tamás Pluzsik1,2, Gábor László Sándor1, Orsolya Németh1, Olga Lukáts1, Zoltán Zsolt Nagy1, Nóra Szentmáry1,3.
Abstract
PURPOSE: To analyse the clinical and microbiological characteristics and preexisting ophthalmic and systemic conditions of infectious keratitis resulting in enucleation/evisceration in a large tertiary referral center in a developed country (Hungary) over a period of 12 years. Patients and Methods. A retrospective review of enucleated/eviscerated eyes undergoing surgery between 2007 and 2018 at the Department of Ophthalmology of Semmelweis University, Budapest, Hungary, with infectious keratitis as the primary indication for enucleation or evisceration. For each subject, clinical history, B-scan ultrasound report, and microbiological analyses were reviewed.Entities:
Year: 2020 PMID: 32509342 PMCID: PMC7254073 DOI: 10.1155/2020/8283131
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Demographic characteristics of patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Number of patients ( | 47 |
| Number of enucleations and eviscerations ( | 48 |
| Number of enucleations ( | 46 (95.8%) |
| Number of eviscerations ( | 2 (4.2%) |
| Sex | |
| Male ( | 18 (38.3%) |
| Female ( | 29 (61.7%) |
| Age at the time of the enucleation or evisceration | 66.4 ± 18.5 years |
| Laterality | |
| Right ( | 23 (47.9%) |
| Left ( | 25 (52.1%) |
Figure 1Age distribution (at the time of surgery) of patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
Medical characteristics of patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Best corrected distance visual acuity (LogMAR) | 2.73 ± 0.36 |
| Number of preexisting ocular factors | 4 ± 2 |
| Number of preexisting systemic diseases | 2 ± 2 |
| Duration of symptoms prior to presentation at our clinic (days) | 21.3 ± 34.2 |
| Location of the corneal ulcer | |
| Central ( | 18 (37.5%) |
| Midperipheral ( | 8 (16.7%) |
| Peripheral ( | 5 (10.4%) |
| Total corneal melting ( | 17 (35.4%) |
| Anterior chamber status | |
| Tyndallization ( | 8 (16.7%) |
| Hypopyon ( | 10 (20.8%) |
| Loss of anterior chamber ( | 4 (8.3%) |
| Not visible or not described ( | 26 (54.2%) |
| Average number of attempted surgeries before enucleation or evisceration to manage corneal ulcer | |
| Penetrating keratoplasty | 2 ± 1 |
| Amniotic membrane transplantation | 2 ± 1 |
Figure 2Annual number of enucleations and eviscerations due to microbial keratitis between 2007 and 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary).
Associated preexisting ophthalmological factors and systemic diseases for patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Ophthalmological factors |
| Systemic diseases |
|
|---|---|---|---|
| Previous cataract surgery | 29 | Hypertension | 30 |
| Previous corneal transplantation | 27 | Cardiac disease | 10 |
| Corneal perforation | 25 | Diabetes mellitus | 10 |
| Glaucoma | 20 | Rheumatoid arthritis | 7 |
| Amniotic membrane transplantation | 16 | Previous tuberculosis | 3 |
| Long-term topical steroid usage | 15 | Hypo/hyperthyroidism | 3 |
| Conjunctival autograft transplantation | 8 | Dementia | 4 |
| Tarsorrhaphy | 7 | History of pulmonary embolism | 3 |
| Previous vitrectomy | 6 | Previous stroke | 2 |
| Previous ocular trauma | 3 | Lyell's syndrome | 2 |
| Previous herpetic keratitis | 3 | Depression | 2 |
| Uveitis | 3 | History of vein thrombosis | 2 |
| Previous corneal refractive surgery | 2 | Sjögren's syndrome | 2 |
| Previous eyelid tumour | 2 | Asthma | 1 |
| Previous dacryocystitis | 2 | Tumour | 1 |
| Age related macular degeneration | 1 | Noncompliance | 1 |
| Ocular mucous membrane pemphigoid | 1 | Intellectual disability | 1 |
| Previous acanthamoeba keratitis | 1 | History of herpes zoster | 1 |
| Lagophthalmus | 1 | Atopic dermatitis | 1 |
| Endocrine ophthalmopathy | 1 | Alcoholism | 1 |
| Contact lens wearing | 1 | Systemic lupus erythematosus | 1 |
| Fuchs' corneal dystrophy | 1 | Social isolation in older age | 1 |
| Amblyopy | 1 | Rosacea | 1 |
| Parkinson's disease | 1 |
Bacteria isolated from cases of infectious keratitis in patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Bacteria |
|
|
| |
|
| 11 |
| | 7 |
| | 1 |
| | 3 |
|
| 8 |
|
| 7 |
| | 3 |
| | 1 |
| | 1 |
| | 2 |
|
| 6 |
|
| 5 |
|
| 2 |
|
| 2 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| |
| Total | 47 |
Antibiotic sensitivity for isolated organisms of patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Bacteria | Antibiotic | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amoxicillin | Oxacillin | Cefazolin | Ceftriaxone | Vancomycin | Ciprofloxacin | Ofloxacin | Levofloxacin | Moxifloxacin | Chloramphenicol | Gentamycin | Tobramycin | Neomycin | |
| % sensitive (number sensitive/number tested) | |||||||||||||
|
| 25% (2/8) | 45.5% (5/11) | 25% (2/8) | n.t. | 100% (9/9) | 55.6% (5/9) | 66.6% (2/3) | 37.5% (3/8) | 28.6% (2/7) | 100% (3/3) | 54.5% (6/11) | 54.5% (6/11) | 100% (3/3) |
| | 20% (1/5) | 42.9% (3/7) | 20% (1/5) | n.t. | 100% (5/5) | 57.1% (4/7) | 100% (1/1) | 40% (2/5) | 40% (2/5) | 100% (2/2) | 57.1% (4/7) | 57.1% (4/7) | 100% (1/1) |
| | 33.3% (1/3) | 50% (2/4) | 33.3% (1/3) | n.t. | 100% (4/4) | 50% (1/2) | 50% (1/2) | 33.3% (1/3) | 0% (0/2) | 100% (1/1) | 50% (2/4) | 50% (2/4) | 100% (2/2) |
|
| 83.3% (5/6) | 85.7% (6/7) | 85.7% (6/7) | n.t. | 100% (4/4) | 66.7% (4/6) | 100% (2/2) | 80% (4/5) | 83.3% (5/6) | 100% (3/3) | 100% (7/7) | 85.7% (6/7) | 100% (2/2) |
|
| 100% (6/6) | 100% (1/1) | n.t. | 100% (6/6) | 100% (4/4) | n.t. | 100% (1/1) | 100% (6/6) | 100% (5/5) | 100% (2/2) | n.t. | n.t. | 50% (1/2) |
|
| 100% (3/3) | 100% (1/1) | n.t. | 100% (3/3) | 100% (2/2) | n.t. | 100% (3/3) | 100% (3/3) | 100% (1/1) | n.t. | n.t. | 0% (0/1) | |
| Other | 100% (3/3) | n.t. | n.t. | 100% (3/3) | 100% (2/2) | n.t. | 100% (1/1) | 100% (3/3) | 100% (2/2) | 100% (1/1) | n.t. | n.t. | 100% (1/1) |
|
| 83.3% (5/6) | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | |
|
| n.t. | n.t. | n.t. | 80% (4/5) | n.t. | 100% (2/2) | n.t. | n.t. | 80% (4/5) | 80% (4/5) | n.t. | ||
|
| 0% (0/2) | n.t. | 0% (0/1) | 100% (2/2) | n.t. | 100% (2/2) | n.t. | 100% (2/2) | 100% (1/1) | n.t. | 100% (2/2) | 100% (2/2) | n.t. |
|
| 0% (0/1) | n.t. | 0% (0/1) | 0% (0/1) | n.t. | 100% (2/2) | n.t. | 100% (2/2) | n.t. | n.t. | 100% (2/2) | 100% (2/2) | n.t. |
|
| 100% (1/1) | n.t. | n.t. | 100% (1/1) | n.t. | n.t. | n.t. | 100% (1/1) | 100% (1/1) | n.t. | n.t. | n.t. | |
|
| n.t. | n.t. | n.t. | n.t. | 100% (1/1) | 0% (0/1) | n.t. | n.t. | 0% (0/1) | n.t. | 0% (0/1) | n.t. | n.t. |
|
| 100% (1/1) | n.t. | n.t. | 100% (1/1) | 100% (1/1) | 0% (0/1) | n.t. | 100% (1/1) | 100% (1/1) | 100% (1/1) | n.t. | n.t. | 0% (0/1) |
|
| 100% (1/1) | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. | n.t. |
|
| n.t. | 100% (1/1) | n.t. | 100% (1/1) | n.t. | n.t. | n.t. | n.t. | 100% (1/1) | n.t. | n.t. | ||
|
| 100% (1/1) | n.t. | 100% (1/1) | 100% (1/1) | n.t. | 100% (1/1) | n.t. | 100% (1/1) | n.t. | n.t. | 100% (1/1) | 100% (1/1) | n.t. |
| % resistant | 33.3% | 36.8% | 50.0% | 7.7% | 0% | 32.1% | 16.7% | 21.4% | 31.8% | 0% | 23.3% | 25% | 25% |
| Total number tested | 33 | 19 | 18 | 13 | 19 | 28 | 6 | 28 | 22 | 9 | 30 | 28 | 8 |
n.t. = not tested.
Antifungal susceptibility of isolated fungi for patients who underwent enucleation or evisceration due to infectious keratitis between January 2007 and December 2018 at the Department of Ophthalmology of Semmelweis University (Budapest, Hungary) (48 eyes of 47 patients).
| Fungi | Antifungal susceptibility | |||
|---|---|---|---|---|
| Amphotericin B | Fluconazole | Natamycin | Voriconazole | |
| % sensitive (number sensitive/number tested) | ||||
|
| 0/1 (0%) | 0/1 (0%) | n.t. | 1/1 (100%) |
|
| 1/1 (100%) | 1/1 (100%) | n.t. | n.t. |
|
| 1/1 (100%) | 1/1 (100%) | n.t. | 1/1 (100%) |
|
| n.t. | 1/1 (100%) | n.t. | 1/1 (100%) |
|
| 0/1 (0%) | n.t. | 1/1 (100%) | 0/1 (0%) |
|
| 1/1 (100%) | n.t. | n.t. | 1/1 (100%) |
| % resistant | 40% | 25% | 0% | 20% |
|
| ||||
| Total number tested | 5 | 4 | 1 | 5 |
n.t. = not tested.